T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 19, 2024. The company is seeking to have the registration statement become effective by 4:00 p.m. on July 29, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration statement's effectiveness via a phone call to their legal representative, N. Danny Shulman of Latham & Watkins LLP, and also to receive written confirmation.

T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 19, 2024. The company is seeking to have the registration statement become effective by 4:00 p.m. on July 29, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration statement's effectiveness via a phone call to their legal representative, N. Danny Shulman of Latham & Watkins LLP, and also to receive written confirmation.